| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/05/2000 | EP1014975A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
| 07/05/2000 | EP1014973A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 07/05/2000 | EP1014970A1 Parasiticidal formulations |
| 07/05/2000 | EP1014968A1 NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 07/05/2000 | EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 07/05/2000 | EP1014965A1 Dietary compositions for enhancing metabolism and alleviating oxidative stress |
| 07/05/2000 | EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/05/2000 | EP1014790A1 Chemical modification of dna using peptide nucleic acid conjugates |
| 07/05/2000 | EP0871664A4 Novel chemokine for mobilizing stem cells |
| 07/05/2000 | EP0788490B1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 07/05/2000 | EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications |
| 07/05/2000 | EP0711296B1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL[5,1-c][1,4]BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS |
| 07/05/2000 | EP0711293B1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZO[1,5-a]INDOL-3-ONE AND THEIR USE AS THERAPEUTIC AGENTS |
| 07/05/2000 | EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 07/05/2000 | EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists |
| 07/05/2000 | EP0528891B1 Method for increasing blood-brain barrier permeability |
| 07/05/2000 | CN1259165A Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain |
| 07/05/2000 | CN1259140A Treatment of insulin resistance with growth hormone secretagogues |
| 07/05/2000 | CN1259138A 17 'beta'-allyloxy (thio) alkyl-androstane derivatives for the modulation of meiosis |
| 07/05/2000 | CN1259137A Estra-5(10), 7-dienes with estrogenic activity |
| 07/05/2000 | CN1259132A Compounds |
| 07/05/2000 | CN1259131A Compounds |
| 07/05/2000 | CN1259126A Pharmacological agents |
| 07/05/2000 | CN1259125A Substituted 3-cyano quinolines |
| 07/05/2000 | CN1259049A Carboxamides useful as 5-HT1F agonists |
| 07/05/2000 | CN1259040A Compositions and methods for inhibiting photoaging of skin |
| 07/05/2000 | CN1258535A Kidney invigorating and blood circulation activating Chinese medicine preparation and its preparation process and application |
| 07/05/2000 | CN1258524A Guihuangpian tablet and its preparation |
| 07/05/2000 | CN1258497A Polymer using in formula of cosmetics |
| 07/05/2000 | CN1054073C Health care oral liquor |
| 07/05/2000 | CN1054064C Traditional Chinese medicine oral liquor for narcotics abstinence |
| 07/05/2000 | CA2293928A1 A novel substituted alkyltetraamine derivative |
| 07/04/2000 | US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer |
| 07/04/2000 | US6083987 Phenylenediamine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant |
| 07/04/2000 | US6083986 Amine derivative substituted indane compound useful for the treatment of cardiac arrhythmias and cell proliferative disorders |
| 07/04/2000 | US6083978 Compounds with a sulfamate group |
| 07/04/2000 | US6083974 Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them |
| 07/04/2000 | US6083973 Methods for inhibiting mucin secretion using RAR α selective antagonists |
| 07/04/2000 | US6083960 Constrained somatostatin agonists and antagonists |
| 07/04/2000 | US6083959 Quinoline derivatives, processes for their preparation and their use as medicaments |
| 07/04/2000 | US6083957 Heterocyclic compounds and their preparation and use |
| 07/04/2000 | US6083956 Optically pure androgen mediator |
| 07/04/2000 | US6083954 Method of treating cystic fibrosis |
| 07/04/2000 | US6083952 Compounds |
| 07/04/2000 | US6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists |
| 07/04/2000 | US6083948 Treating anxiety, depression, and other psychiatric and neurological disorders |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 07/04/2000 | US6083938 Pyridinylbisphosphonates for use as a therapeutical agent |
| 07/04/2000 | US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/04/2000 | US6083926 Water soluble vitamin B12 receptor modulating agents and methods related thereto |
| 07/04/2000 | US6083924 DnaB of staphylococcus aureus |
| 07/04/2000 | US6083918 Use of collagen for the treatment of degenerative articular processes |
| 07/04/2000 | US6083906 Method of regulating nitric oxide production or arthritis with soluble IL-17 receptor |
| 07/04/2000 | US6083904 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
| 07/04/2000 | US6083756 Identifying infant's susceptibility by detecting helicobacter pylori in sample of blood, saliva, dental plaque, feces or exhaled air collected from infant's mother, close relative, or person expected to come into close bodily contact |
| 07/04/2000 | US6083735 Programmed cell death genes and proteins |
| 07/04/2000 | US6083720 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
| 07/04/2000 | US6083719 Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesis |
| 07/04/2000 | US6083706 Inhibitors of leaderless protein export |
| 07/04/2000 | US6083705 Screening for chemical compound which preferentially binds to binding protein; incubation of compound with cells expressing binding protein, detecting preferential binding of compound to surface of cell not normally expressing binding protein |
| 07/04/2000 | US6083515 Treating inflammation, pain, gastrointestinal lesions or fever in an animal in need thereof with reduction of the gastrointestinal toxicity or renal toxicity of the nonsteroidal antiinflammatory drug |
| 07/04/2000 | US6083510 High molecular weight extracts of Convolvulus arvensis field (field bindweed) |
| 07/04/2000 | US6083483 For the modulation of the motility and peristalsis of the hollow organs of the urogenital and gastrointestinal tract |
| 07/04/2000 | CA2124792C Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| 07/04/2000 | CA2067374C Osteogenesis promoter |
| 07/04/2000 | CA2025212C (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 07/04/2000 | CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents |
| 06/30/2000 | CA2293890A1 A novel treatment for pre-eclampsia and related diseases |
| 06/29/2000 | WO2000037927A1 High energy phototherapeutic agents |
| 06/29/2000 | WO2000037637A1 Novel protein and dna thereof |
| 06/29/2000 | WO2000037620A1 Crystalline form of activated trap and use thereof for structure-based drug design |
| 06/29/2000 | WO2000037616A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders |
| 06/29/2000 | WO2000037613A2 Human akt-3 |
| 06/29/2000 | WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 06/29/2000 | WO2000037499A1 Topoisomerase ii inhibitor |
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
| 06/29/2000 | WO2000037473A1 Epothilone derivatives and their use as antitumor agents |
| 06/29/2000 | WO2000037472A2 Substituted pirroloindoles |
| 06/29/2000 | WO2000037470A1 Antihistaminic spiro compounds |
| 06/29/2000 | WO2000037468A1 DIBENZO[a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF |
| 06/29/2000 | WO2000037466A1 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS |
| 06/29/2000 | WO2000037464A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| 06/29/2000 | WO2000037462A1 Non-peptide nk1 receptors antagonists |
| 06/29/2000 | WO2000037459A1 Tricyclic farnesyl protein transferase inhibitors |
| 06/29/2000 | WO2000037458A1 Farnesyl protein transferase inhibitors |
| 06/29/2000 | WO2000037456A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
| 06/29/2000 | WO2000037451A1 Il-5 inhibiting 6-azauracil derivatives |
| 06/29/2000 | WO2000037450A1 NEW β-AMIDE AND β-SULFONAMIDE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 06/29/2000 | WO2000037441A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | WO2000037436A1 Sulfonamide hydroxamates |
| 06/29/2000 | WO2000037426A1 Novel oxo-aminotetralin compounds useful in pain management |
| 06/29/2000 | WO2000037422A2 Ion channel modulating agents |
| 06/29/2000 | WO2000037358A1 NOVEL sPLA2 INHIBITORS |
| 06/29/2000 | WO2000037141A1 Combination chemotherapy |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 06/29/2000 | WO2000037099A2 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor |
| 06/29/2000 | WO2000037096A2 Treatment of hepatitis c virus infections with interleukin-10 |
| 06/29/2000 | WO2000037093A1 Bone resorption inhibitors |
| 06/29/2000 | WO2000037089A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |